Engineering Next-Generation CAR cell Therapies to Navigate Challenges in Liquid & Solid Tumors
Time: 1:45 pm
day: Day Two - Track A PM
Details:
- SENTI-202 is a CAR-NK cell therapy that uses logic gated gene circuits to address these challenges and has shown positive preliminary clinical data in AML
- Solid tumors pose additional challenges. Senti has leveraged high throughput screening and machine learning to engineer next generation gene circuits, which work in both T and NK cells, designed for improved performance against solid tumors
